[1] Podschun, R. and Ullmann, U. (1998). Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clinical microbiology reviews, 11(4), 589-603.
[2] Kang, C. I., Song, J. H., Chung, D. R., Peck, K. R., Ko, K. S., Yeom, J. S., et al. (2011). Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. Journal of Infection, 62(1), 26-33.
[3] Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., et al. (2014). Multistate point-prevalence survey of health care–associated infections. New England Journal of Medicine, 370(13), 1198-1208.
[4] Álvarez, D., Merino, S., Tomás, J. M., Benedí, V. J., et al. (2000). Capsular polysaccharide is a major complement resistance factor in lipopolysaccharide O side chain-deficient Klebsiella pneumoniae clinical isolates. Infection and immunity, 68(2), 953-955.
[5] Cortés, G., Borrell, N., de Astorza, B., Gómez, C., Sauleda, J., et al. (2002). Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infection and immunity, 70(5), 2583-2590.
[6] Paczosa, M. K. and Mecsas, J. (2016). Klebsiella pneumoniae: going on the offense with a strong defense. Microbiology and molecular biology reviews, 80(3), 629-661.
[7] Sellick, J. A. and Russo, T. A. (2018). Getting hypervirulent Klebsiella pneumoniae on the radar screen. Current opinion in infectious diseases, 31(4), 341-346.
[8] Fang, C. T., Chuang, Y. P., Shun, C. T., Chang, S. C., et al. (2004). A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. The Journal of experimental medicine, 199(5), 697-705.
[9] Russo, T. A. and Marr, C. M. (2019). Hypervirulent Klebsiella pneumoniae. Clinical microbiology reviews, 32(3), 10-1128.
[10] Pomakova, D. K., Hsiao, C. B., Beanan, J. M., Olson, R., MacDonald, U., Keynan, Y., et al. (2012). Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. European Journal of clinical microbiology & infectious diseases, 31, 981-989.
[11] Raymond, K. N., Allred, B. E., and Sia, A. K. (2015). Coordination chemistry of microbial iron transport. Accounts of chemical research, 48(9), 2496-2505.
[12] Boiteau, R. M., Mende, D. R., Hawco, N. J., McIlvin, M. R., Fitzsimmons, J. N., Saito, M. A., et al. (2016). Siderophore-based microbial adaptations to iron scarcity across the eastern Pacific Ocean. Proceedings of the National Academy of Sciences, 113(50), 14237-14242.
[13] Bullen, J. J., Rogers, H. J., and Leigh, L. (1972). Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br med J, 1(5792), 69-75.
[14] Carniel, E. (2001). The Yersinia high-pathogenicity island: an iron-uptake island. Microbes and infection, 3(7), 561-569.
[15] Miethke, M. and Marahiel, M. A. (2007). Siderophore-based iron acquisition and pathogen control. Microbiology and molecular biology reviews, 71(3), 413-451.
[16] Brock, J. H., Williams, P. H., Liceaga, J., and Wooldridge, K. G. (1991). Relative availability of transferrin-bound iron and cell-derived iron to aerobactin-producing and enterochelin-producing strains of Escherichia coli and to other microorganisms. Infection and immunity, 59(9), 3185-3190.
[17] Hsieh, P. F., Lin, T. L., Lee, C. Z., Tsai, S. F., and Wang, J. T. (2008). Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. Journal of Infectious Diseases, 197(12), 1717-1727.
[18] El Fertas-Aissani, R., Messai, Y., Alouache, S., and Bakour, R. (2013). Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathologie Biologie, 61(5), 209-216.
[19] Russo, T. A., Olson, R., Fang, C. T., Stoesser, N., Miller, M., MacDonald, U., et al. (2018). Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. Journal of clinical microbiology, 56(9), 10-1128.
[20] Yu, W. L., Ko, W. C., Cheng, K. C., Lee, C. C., Lai, C. C., and Chuang, Y. C. (2008). Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagnostic microbiology and infectious disease, 62(1), 1-6.
[21] Russo, T. A., Olson, R., MacDonald, U., Metzger, D., Maltese, L. M., Drake, E. J., and Gulick, A. M. (2014). Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Infection and immunity, 82(6), 2356-2367.
[22] Schwyn, B. and Neilands, J. B. (1987). Universal chemical assay for the detection and determination of siderophores. Analytical biochemistry, 160(1), 47-56.
[23] Raaska, L., Viikari, L., and Mattila-Sandholm, T. (1993). Detection of siderophores in growing cultures of Pseudomonas spp. Journal of industrial microbiology and Biotechnology, 11(3), 181-186.
[24] Mahon, C. R. and Lehman, D. C. (2022). Textbook of diagnostic microbiology-e-book. Elsevier Health Sciences.
[25] Louden, B. C., Haarmann, D., and Lynne, A. M. (2011). Use of blue agar CAS assay for siderophore detection. Journal of microbiology & biology education, 12(1), 51-53.
[26] Namikawa, H., Niki, M., Niki, M., Oinuma, K. I., Yamada, K., Nakaie, K., et al. (2022). Siderophore production as a biomarker for Klebsiella pneumoniae strains that cause sepsis: A pilot study. Journal of the Formosan Medical Association, 121(4), 848-855.
[27] Qing-Ping, H. and Jian-Guo, X. (2011). A simple double-layered chrome azurol S agar (SD-CASA) plate assay to optimize the production of siderophores by a potential biocontrol agent Bacillus. African Journal of Microbiology Research, 5(25), 4321-4327.
[28] Payne, S. M. (1993). Iron acquisition in microbial pathogenesis. Trends in microbiology, 1(2), 66-69.
[29] Arora, N. K. and Verma, M. (2017). Modified microplate method for rapid and efficient estimation of siderophore produced by bacteria. 3 Biotech, 7(6), 381.
[30] Martínez, J. L., and Baquero, F. (2002). Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clinical microbiology reviews, 15(4), 647-679.
[31] Li, W., Sun, G., Yu, Y., Li, N., Chen, M., Jin, R., et al. (2014). Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clinical infectious diseases, 58(2), 225-232.
[32] Liu, C. and Guo, J. (2019). Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor. Annals of clinical microbiology and antimicrobials, 18, 1-11.
[33] Choby, J. E., Howard‐Anderson, J., and Weiss, D. S. (2020). Hypervirulent Klebsiella pneumoniae–clinical and molecular perspectives. Journal of internal medicine, 287(3), 283-300.
[34] Wang, L., Shen, D., Wu, H., and Ma, Y. (2017). Resistance of hypervirulent Klebsiella pneumoniae to both intracellular and extracellular killing of neutrophils. PLoS One, 12(3), e0173638.
[35] Brisse, S., Fevre, C., Passet, V., Issenhuth-Jeanjean, S., Tournebize, R., Diancourt, L., and Grimont, P. (2009). Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PloS one, 4(3), e4982.
[36] Wu, K. M., Li, L. H., Yan, J. J., Tsao, N., Liao, T. L., Tsai, H. C., et al. (2009). Genome sequencing and comparative analysis of Klebsiella pneumoniae NTUH-K2044, a strain causing liver abscess and meningitis. Journal of Bacteriology, 191(14), 4492-4501.
[37] Fung, C. P., Chang, F. Y., Lee, S. C., Hu, B. S., Kuo, B. I., Liu, C. Y., et al. (2002). A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?. Gut, 50(3), 420-424.
[38] Cheng, H. Y., Chen, Y. S., Wu, C. Y., Chang, H. Y., Lai, Y. C., and Peng, H. L. (2010). RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. Journal of Bacteriology, 192(12), 3144-3158.
[39] Monem Mohammed, K. A., Abdalla Ali Elhag, S., Tag Elser Sed Ahmed, S., Taher Gorish, B. M., Osman Noorelhuda Mohammed, S., Ismail Yahia Abdelmula, W., ... and H Ali, A. (2022). Molecular Detection of Virulence genes (rmpA2, iuc & iroB) of Hypervirulent Klebsiella pneumoniae in Clinical Isolates from Patients in Khartoum State, Sudan. Asian Journal of Research in Infectious Diseases, 9(4), 23-31.
[40] Russo, T. A., Shon, A. S., Beanan, J. M., Olson, R., MacDonald, U., Pomakov, A. O., and Visitacion, M. P. (2011). Hypervirulent K. pneumoniae secretes more and more active iron-acquisition molecules than “classical” K. pneumoniae thereby enhancing its virulence. PLoS One, 6(10), e26734.
[41] Li, J., Ren, J., Wang, W., Wang, G., Gu, G., Wu, X., et al. (2018). Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections. European Journal of Clinical Microbiology & Infectious Diseases, 37, 679-689.
[42] Liu, Y. M., Li, B. B., Zhang, Y. Y., Zhang, W., Shen, H., Li, H., and Cao, B. (2014). Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrobial agents and chemotherapy, 58(9), 5379-5385.